Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ).
Shanghai Pharmaceuticals Holding Co., Ltd. announced the nomination of Dr. WAN Jun as an independent non-executive director, aiming to enhance the board’s diversity. Dr. WAN Jun’s extensive experience in transplant oncology and immunology, along with her leadership roles in various prestigious organizations, positions her as a valuable addition to the company. The appointment is subject to shareholder approval and aligns with the company’s efforts to meet gender diversity requirements as per Hong Kong Stock Exchange regulations.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company based in China, primarily operating in the pharmaceutical industry. The company focuses on the distribution of pharmaceutical products and medical devices, and it is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -17.28%
Average Trading Volume: 6,976
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.16B
Find detailed analytics on 2607 stock on TipRanks’ Stock Analysis page.
